151 related articles for article (PubMed ID: 9760153)
1. Transient myeloproliferative disorder with 11q23 aberration in two neonates with Down syndrome.
Granzen B; Bernhard B; Reinisch I; Skopnik H; Mertens R
Ann Hematol; 1998; 77(1-2):51-4. PubMed ID: 9760153
[TBL] [Abstract][Full Text] [Related]
2. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
[TBL] [Abstract][Full Text] [Related]
3. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
[TBL] [Abstract][Full Text] [Related]
4. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.
Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR
Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369
[TBL] [Abstract][Full Text] [Related]
5. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
[TBL] [Abstract][Full Text] [Related]
6. Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism.
Zubizarreta P; Muriel FS; Fernández Barbieri MA
Med Pediatr Oncol; 1995 Jul; 25(1):60-4. PubMed ID: 7753004
[TBL] [Abstract][Full Text] [Related]
7. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate.
Polski JM; Galambos C; Gale GB; Dunphy CH; Evans HL; Batanian JR
J Pediatr Hematol Oncol; 2002 Jan; 24(1):50-4. PubMed ID: 11902741
[TBL] [Abstract][Full Text] [Related]
8. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome.
Barnett PL; Clark AC; Garson OM
Med Pediatr Oncol; 1990; 18(5):347-53. PubMed ID: 2142749
[TBL] [Abstract][Full Text] [Related]
9. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for early death in transient myeloproliferative disorder without phenotypic features of Down syndrome: a case report and literature review.
Kawase K; Azuma E; Ohshita H; Tanaka T; Hanada Y; Sasaki T; Sugimoto M; Togawa T; Kouwaki M; Ito T; Hirayama M; Koyama N
J Pediatr Hematol Oncol; 2012 Aug; 34(6):475-9. PubMed ID: 22510770
[TBL] [Abstract][Full Text] [Related]
11. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
12. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
[TBL] [Abstract][Full Text] [Related]
13. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
Thirman MJ; Gill HJ; Burnett RC; Mbangkollo D; McCabe NR; Kobayashi H; Ziemin-van der Poel S; Kaneko Y; Morgan R; Sandberg AA
N Engl J Med; 1993 Sep; 329(13):909-14. PubMed ID: 8361504
[TBL] [Abstract][Full Text] [Related]
14. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
15. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
Rowley JD
Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
[TBL] [Abstract][Full Text] [Related]
16. Transient myeloproliferative disorder with partial trisomy 21.
Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
[TBL] [Abstract][Full Text] [Related]
17. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
[TBL] [Abstract][Full Text] [Related]
18. Vesiculopustular eruption associated with transient myeloproliferative disorder.
Nornhold E; Li A; Rothman IL; Lakshminrusimha S; Helm TN
Cutis; 2009 May; 83(5):234-6. PubMed ID: 19537279
[TBL] [Abstract][Full Text] [Related]
19. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis.
Martinez-Climent JA; Thirman MJ; Espinosa R; Le Beau MM; Rowley JD
Leukemia; 1995 Aug; 9(8):1299-304. PubMed ID: 7643616
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
